Colon and Breast Cancer Diagnostics. Clinical Protocol Associated With Cancer of the Breast.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Institut Curie
- Enrollment
- 180
- Locations
- 1
- Primary Endpoint
- Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis
- Last Updated
- 15 years ago
Overview
Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tumor and blood samples from women with breast cancer.
Detailed Description
OBJECTIVES: Primary * Assess relapse locally or remotely using biomarkers collected from primary tumor and blood samples from women with breast cancer during the first 2 years after diagnosis. Secondary * Evaluate all relapses. * Assess survival without relapse. * Determine correlation between biomarkers and relapse. OUTLINE: Primary tumor and blood samples collected during usual care of patients during the first 2 years after diagnosis are analyzed for biomarkers useful in monitoring and diagnosing breast cancer.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis